A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C

Takuro Arimura1, Takeharu Hayashi, Hajime Terada

  • 1Department of Molecular Pathogenesis, Medical Research Institute, and Laboratory of Genome Diversity, School of Biomedical Science, Tokyo Medical and Dental University, Tokyo 101-0062, Japan.

Insights

Researchers identified a novel Cypher/ZASP gene mutation (D626N) linked to late-onset dilated cardiomyopathy in Japanese patients. This mutation alters protein interactions, suggesting a new mechanism for heart muscle disease.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Basis of Heart Disease

Background:

  • Dilated cardiomyopathy involves ventricular dilation and systolic dysfunction.
  • Genetic mutations in cytoskeletal proteins are known causes, but don't explain all cases.
  • Cypher/ZASP, a Z-disc protein, is a candidate gene, supported by knockout mouse studies.

Purpose of the Study:

  • To investigate sequence variations in the Cypher/ZASP gene in Japanese patients with dilated cardiomyopathy.
  • To identify potential novel genetic causes of dilated cardiomyopathy.

Main Methods:

  • Screened 96 unrelated Japanese dilated cardiomyopathy patients for Cypher/ZASP mutations.
  • Conducted family studies to confirm mutation inheritance.
  • Utilized yeast two-hybrid and pull-down assays to examine biochemical effects of the mutation.

Main Results:

  • A novel D626N mutation in the Cypher/ZASP gene was found in a familial case, absent in controls.
  • The mutation segregated with the disease in affected family members.
  • Biochemical assays showed the D626N mutation increases Cypher/ZASP's affinity for protein kinase C.

Conclusions:

  • The D626N Cypher/ZASP mutation is associated with late-onset dilated cardiomyopathy.
  • This mutation may cause disease by altering protein kinase C binding.
  • Identifies a novel pathogenic mechanism for dilated cardiomyopathy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Mutations02:27

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously during DNA replication or be induced by environmental factors. Mutations can be characterized in several ways: by whether and how they alter the amino acid sequence of the protein, by the scale of the DNA affected, and by whether they affect somatic or germline cells.Consequences of Point Mutations at the Molecular LevelMutations that affect a single nucleotide are called point mutations. When point mutations...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...